ONCOLOGY

CARDIOTOXICITY & ARTA IN PROSTATE CANCER : Uncovering the underrecognized risk? 

🩺  FREE LIVE WEBINAR – 02/10/2025 – 19:30–20:30
Prostate cancer therapies are evolving rapidly – but what about their long-term cardiovascular impact? In this session, experts will explore the often-overlooked risks of ARTA treatments. An essential session for clinicians focused on long-term prostate cancer care.

🎓 Accreditation points available for participants
👩‍⚕️ Please note: this content is intended for healthcare professionals only.

Moderator:

Dr Berlinde von Kemp, UZ Brussel

Expert panel:

Prof Lucas Van Aelst, UZ Leuven
Dr Ruben De Wilde, UZ Brussel

Programme:

20:00 - 20:05 - Introduction - Prof Dr Guy Brusselle
20:05 - 20:20 - Highlights of ATS 2025: asthma - Prof Dr Guy Brusselle
20:20 - 20:25 - Q&A
20:25 - 20:40 - Highlights of ATS 2025 in the treatment of COPD - Prof Dr Marie Bruyneel
20:40 - 20:45 - Q&A
20:45 - 21:00 - Highlights of ATS 2025 in the treatment of ILD - Prof Dr Wim Wuyts
21:00 - 21:05 - Q&A
21:05 - 21:20 - Highlights of ATS 2025 in the treatment of respiratory infections - Prof Dr Pascal Van Bleyenbergh
21:20 - 21:25 - Q&A
21:25 - 21:30 - Closing - Prof Dr Guy Brusselle

ONCOLOGY

CARDIOTOXICITY & ARTA IN PROSTATE CANCER : Uncovering the underrecognized risk? 

Moderator:
Dr Berlinde von Kemp, UZ Brussel


Expert panel:
Prof Lucas Van Aelst, UZ Leuven
Dr Ruben De Wilde, UZ Brussel

This course is currently available for physicians only.

Made possible with the financial support of our partners.
All videos are developed independently and are non-promotional.